These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1112087)

  • 1. The effect of intrauterine progesterone on the hypothalamic-hypophyseal-ovarian axis in humans.
    Tillson SA; Marian M; Hudson R; Wong P; Pharriss B; Aznar R; Martinez-Manautou J
    Contraception; 1975 Feb; 11(2):179-92. PubMed ID: 1112087
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intrauterine progesterone-releasing devices on the hypothalamic-hypophyseal-ovarian axis in women.
    Carenza L; Ermini M; Pala A; Benagiano G
    Patol Clin Ostet Ginecol; 1976; 4(3):109-15. PubMed ID: 992205
    [No Abstract]   [Full Text] [Related]  

  • 3. Interrelationships between pituitary gonadotrophins and ovarian steroids in baboons during continuous intrauterine progesterone treatment.
    Tillson SA; Swisher DA; Pharriss BB; Erickson RE; Neill JD
    Biol Reprod; 1976 Oct; 15(3):291-6. PubMed ID: 822890
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid modulation of the hypothalamic-pituitary system in the secretion of reproductive hormones.
    Yen SS; Lasley B; Wang C; Ehara Y
    J Steroid Biochem; 1975 Jun; 6(6):1047-53. PubMed ID: 809617
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the "pill-a-month" on the hypothalamic-pituitary-ovarian axis.
    Nudemberg F; Kothari M; Karam K; Taymor ML
    Fertil Steril; 1973 Mar; 24(3):185-90. PubMed ID: 4691360
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroendocrinology of the menstrual cycle in humans.
    Shaw RW
    Clin Endocrinol Metab; 1978 Nov; 7(3):531-59. PubMed ID: 365398
    [No Abstract]   [Full Text] [Related]  

  • 8. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
    Hemrika DJ; Slaats EH; Schoemaker J
    Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of norgestrel administered intermittently on pituitary ovarian function.
    Craft I; Foss GL; Warren RJ; Fotherby K
    Contraception; 1975 Nov; 12(5):589-98. PubMed ID: 1192745
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of norethisterone on pituitary and ovarian function.
    Collins WP; Koullapis EN; Ferguson KM; Biswas S; Sharples MJ; Sommerville IF
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):357-67. PubMed ID: 4406549
    [No Abstract]   [Full Text] [Related]  

  • 13. The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observations of biological action of somatostatin.
    Yen SS; Lasley BL; Wang CF; Leblanc H; Siler TM
    Recent Prog Horm Res; 1975; 31():321-63. PubMed ID: 1105718
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic tests of hypothalamic and pituitary function in women treated with danazol.
    Fraser IS; Markham R; McIlveen J; Robinson M
    Fertil Steril; 1982 Apr; 37(4):484-8. PubMed ID: 6802676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New evidence for an anti-estrogenic action of clomiphene citrate in women.
    Vaitukaitis JL; Bermudez JA; Cargille CM; Lipsett MB; Ross GT
    J Clin Endocrinol Metab; 1971 Apr; 32(4):503-8. PubMed ID: 4926256
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle.
    Fraser IS; Markham R; Robinson M; Thorburn GD
    Fertil Steril; 1982 Apr; 37(4):489-93. PubMed ID: 6802677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocrinology of ovarian steroid secretion.
    Baird DT
    Eur J Obstet Gynecol Reprod Biol; 1974; 4(1):31-9. PubMed ID: 4607188
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
    McPherson JC; Costoff A; Mahesh VB
    Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound.
    Skouby SO
    Contraception; 1976 Nov; 14(5):529-39. PubMed ID: 989747
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolactin, follicle-stimulating and luteinizing hormone, estradiol and progesterone content in the blood in sexual infantilism].
    Khamad'ianov UR; Laricheva IP; Smirnova LK
    Akush Ginekol (Mosk); 1981 Jul; (7):8-11. PubMed ID: 6795950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.